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1. INTRODUCTION {#jcmm14891-sec-0001}
===============

Mesenchymal stem cells (MSCs) can differentiate into bone, cartilage and fat cells, which play important roles in development, homeostasis, post‐natal growth, repair and regeneration.[1](#jcmm14891-bib-0001){ref-type="ref"}, [2](#jcmm14891-bib-0002){ref-type="ref"} Because of their ability to self‐renew with a high proliferation rate, MSCs are a common source of stem cells in clinical applications to regenerate damaged organs and tissues.[3](#jcmm14891-bib-0003){ref-type="ref"}, [4](#jcmm14891-bib-0004){ref-type="ref"} Numerous studies indicate that the major sources for MSCs in the clinical setting are adipose tissue and bone marrow; however, these resources are limited because there are strict donor requirements.[5](#jcmm14891-bib-0005){ref-type="ref"}, [6](#jcmm14891-bib-0006){ref-type="ref"}, [7](#jcmm14891-bib-0007){ref-type="ref"} Therefore, alternative sources obtained from neonatal or primitive tissues, such as the amnion, placenta, synovial fluid and umbilical cord, have been explored.[2](#jcmm14891-bib-0002){ref-type="ref"}, [8](#jcmm14891-bib-0008){ref-type="ref"}, [9](#jcmm14891-bib-0009){ref-type="ref"}, [10](#jcmm14891-bib-0010){ref-type="ref"}

The umbilical cord (UC) is an attractive source of MSCs as it can be obtained by non‐invasive methods without harm to mothers or their children.[11](#jcmm14891-bib-0011){ref-type="ref"} The UC possesses immunosuppressive activity and produces an abundance of MSCs.[12](#jcmm14891-bib-0012){ref-type="ref"}, [13](#jcmm14891-bib-0013){ref-type="ref"} UC‐derived MSCs (UC‐MSC) are one type of multipotent adult stem cell, which has the potential to differentiate into various cell types, thereby making these cells a possible resource for cell‐based therapies. Human umbilical cord‐derived mesenchymal stem cells have some characteristics in common with MSCs obtained from adipose tissue and bone marrow, including a fibroblastoid morphology and a similar set of surface proteins, as well the ability to differentiate into different cell types.[14](#jcmm14891-bib-0014){ref-type="ref"}, [15](#jcmm14891-bib-0015){ref-type="ref"}

Previous studies have shown that MSCs also exist in synovial fluid (SF).[16](#jcmm14891-bib-0016){ref-type="ref"}, [17](#jcmm14891-bib-0017){ref-type="ref"} In the presence of an injury or osteoarthritis, the number of MSCs from SF increases significantly in order to help recruit mesenchymal progenitor cells to promote spontaneous healing and restore homeostasis.[17](#jcmm14891-bib-0017){ref-type="ref"} SF‐derived MSCs (SF‐MSCs) are a viable option for syngeneic transplantation for cartilage regeneration.[18](#jcmm14891-bib-0018){ref-type="ref"}, [19](#jcmm14891-bib-0019){ref-type="ref"} SF‐MSCs are ideal for clinical applications because SF can be obtained arthroscopically without the donor undergoing invasive surgery.

In recent years, single‐cell genomics has become an incredibly powerful tool to help uncover the genetic structure and population dynamics of unicellular organisms,[20](#jcmm14891-bib-0020){ref-type="ref"}, [21](#jcmm14891-bib-0021){ref-type="ref"}, [22](#jcmm14891-bib-0022){ref-type="ref"}, [23](#jcmm14891-bib-0023){ref-type="ref"} as well as cancer cells,[24](#jcmm14891-bib-0024){ref-type="ref"} and has provided insight into the developmental lineages[25](#jcmm14891-bib-0025){ref-type="ref"} in multicellular organisms. Single‐cell RNA‐sequencing (scRNA‐seq) can be used to analyse differences in the transcriptome of various cells,[26](#jcmm14891-bib-0026){ref-type="ref"}, [27](#jcmm14891-bib-0027){ref-type="ref"} discover novel cell types and provide insights into the regulatory networks that function in ontogenetic development.[28](#jcmm14891-bib-0028){ref-type="ref"} scRNA‐seq is an efficient method for analysing changes in gene expression, and it has been performed successfully in many different tissue types.[29](#jcmm14891-bib-0029){ref-type="ref"}, [30](#jcmm14891-bib-0030){ref-type="ref"}, [31](#jcmm14891-bib-0031){ref-type="ref"} In order to uncover information about the subpopulations that exist in MSCs and analyse the differentially expressed genes (DEGs) of these subgroups, we used scRNA‐seq to perform transcriptomic profiling in hUC‐MSCs and hSF‐MSCs. Furthermore, using clustering, principle components analysis (PCA), t‐Distributed Stochastic Neighbor Embedding (t‐SNE), gene set enrichment analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, we were able to identify subgroups and activated pathways within these populations of MSCs.

2. MATERIALS AND METHODS {#jcmm14891-sec-0002}
========================

2.1. Ethics statement {#jcmm14891-sec-0003}
---------------------

This study was conducted using protocols approved by the Ethical Committee of the Shenzhen People\'s Hospital. Informed consents were obtained from all participants.

2.2. Isolation and culture of hUC‐MSCs {#jcmm14891-sec-0004}
--------------------------------------

Under sterile conditions, UC units (8‐10 cm) were collected from the puerpera of full‐term deliveries and were immediately saved in cold saline (0°C). The blood vessels and outer membrane were removed by surgical blades, and the Wharton jelly (WJ) tissue was cut using eye scissors. The minced tissues were then placed in a 10‐cm culture dish at 1‐cm intervals and were maintained in culture medium (MesenGro Medium supplemented with 10% FBS, 1% penicillin‐streptomycin and 10% MesenGro Supplement) at 37°C with 5% CO~2~ and 90% RH. After 48 hours, the medium was removed to eliminate non‐adherent cells and replaced with fresh medium. The complete culture medium was changed every 3 days. We selected distinct cell subpopulations, and we assumed that these subpopulations were efficient and sustainable. Colonies smaller than 2 mm in diameter were ignored. The clustered hUC‐MSCs were digested with trypsin and resuspended with complete culture medium at a density of 2.0 × 10^4^ cells/cm^2^ into a 25‐mm^2^ vented culture bottle. The CD90^+^ hUC‐MSCs were collected by immunomagnetic beads and were identified under more stringent measures. After approximately three generations, the hUC‐MSCs were sterilely obtained to prepare a monoplast suspension of more than 6.0 × 10^5^ cells, with a survival rate \>90% and cell diameter \<30 μm. The hUC‐MSCs samples were then sent to GENERGY BIO (Shanghai, China) for scRNA‐seq analysis.

2.3. Isolation and culture of hSF‐MSCs {#jcmm14891-sec-0005}
--------------------------------------

The samples were collected during arthroscopic procedures from patients suffering from an intra‐articular ligament injury of the knee joint. Isotonic saline solution was injected into the joint, the knee was moved several times, and then, SF (50‐100 mL) mixed with saline solution was collected in γ‐sterilized centrifuge tubes. Within 1‐4 hours, the fluid was filtered with a cell strainer (40 μm nylon) to remove debris. The filtered fluid was gathered in γ‐sterilized centrifuge tubes and centrifuged at 405 *g* for 10 minutes at room temperature. The cell pellet was resuspended in culture medium (MesenGro Medium supplemented with 10% FBS, 1% penicillin‐streptomycin and 10% MesenGro Supplement) and plated in 100‐mm dishes after centrifugation. After 48 hours, the medium was withdrawn to remove non‐adherent cells and replaced with fresh medium. The complete culture medium was changed every 3 days. We selected distinct cell subpopulations and assumed that these units were efficient and sustainable. The colonies smaller than 2 mm in diameter were discarded using a cell scraper (Corning Inc). Then, the distinct cell subpopulation was digested in cloning cylinders (Sigma‐Aldrich) and used to inoculate a new dish as passage 1. Passage 3 (P3) cells were used for the scRNA‐seq analysis.

2.4. The scRNA‐seq analysis {#jcmm14891-sec-0006}
---------------------------

The hUC‐MSCs and hSF‐MSCs samples were sent to GENERGY BIO for scRNA‐seq analysis (Figure [1](#jcmm14891-fig-0001){ref-type="fig"}) by following previously published protocols.[29](#jcmm14891-bib-0029){ref-type="ref"}, [31](#jcmm14891-bib-0031){ref-type="ref"} Briefly, cell counting was performed using a Countess^®^ II Automated Cell Counter and cell concentration was adjusted to 1.0 × 10^6^ cells/mL. Cellular suspensions were placed on a Chromium™ Single‐Cell Instrument (10 × Genomics) to obtain single‐cell Gel bead in EMulsion (GEM). ScRNA‐seq libraries were prepared using the Chromium™ Single‐Cell Bead and Library Kit. cDNA was sheared to 200 bp using a Covaris M220 (Covaris). Sequencing libraries were constructed using the Chromium™ Single‐Cell Library Kit, following these steps: end repair and A‐tailing, adapter ligation, post‐ligation cleanup with SPRIselect, and sample index PCR and cleanup. The barcode sequencing libraries were quantified using qPCR.

![10 × Genomics single‐cell technology enables the profiling of RNAs from thousands of single cells simultaneously. Cells were combined with reagents in one channel of a chip. Reverse transcription took place inside each GEM, after which cDNAs were pooled to perform amplification and library construction in bulk. Gel beads loaded with primers and barcoded oligonucleotides were first mixed with cells and reagents, and subsequently mixed with oil‐surfactant solution at a microfluidic junction. Single‐cell GEMs were collected in the GEM outlet. Finished library molecules consisted of Illumina adapters and sample indices, which allowed for pooling and sequencing of multiple libraries on a next‐generation short read sequencer](JCMM-24-1945-g001){#jcmm14891-fig-0001}

The Cell Ranger Single‐Cell Software Suite was used to perform sample demultiplexing, barcode processing and single‐cell gene counting. First, sample demultiplexing was performed to generate FASTQs for the paired‐end Read1 and Read2. Second, Chromium™ barcodes and unique molecular identifiers (UMIs) were filtered. Third, PCR was marked if read pairs matched with a barcode sequence, a UMI tag and a gene ID. Cell barcodes were determined based on the distribution of UMI counts. The number of reads that provided valid information was determined based on whether the reads had the following four characteristics: valid barcodes, a valid UMI, a cell barcode and the ability to be confidently mapped to exons. Sequencing data could be combined by counting non‐duplicated reads and subsampled to obtain a given number of UMI counts per cell.

The gene‐cell‐barcode matrix was concatenated. Only genes with at least one UMI count detected in at least one cell were used. Unique molecular identifier normalization was performed by first dividing UMI counts, followed by multiplication by the median total UMI counts across all cells. Each gene was normalized such that its mean signal was 0, and standard deviation was 1. Principle components analysis was run on the normalized gene‐barcode matrix. The normalized UMI counts of each gene were used to show expression of a marker in a t‐SNE plot.

To identify genes that were enriched in a specific cluster, the mean expression of each gene was calculated across all cells in the cluster. Each gene from the cluster was then compared to the median expression of the same gene in all other cell clusters. Genes were ranked based on their expression difference, and the top 10 enriched genes from each cluster were selected. For hierarchical clustering, pair‐wise correlation between each cluster was calculated, and centred expression of each gene was used to generate a heat map. Gene Ontology and KEGG term information was downloaded from the UniProtKB database. Both GO and KEGG terms with a *P*‐value \< .05 were considered to be significantly enriched.

2.5. Statistical analysis {#jcmm14891-sec-0007}
-------------------------

Data are available at <http://support.10%D7genomics.com/single-cell/datasets>, and the analysis code is available at <https://github.com/10%D7Genomics/single-cell-3prime-paper>.

3. RESULTS {#jcmm14891-sec-0008}
==========

3.1. The scRNA‐seq profiles of hUC‐MSCs and hSF‐MSCs by 10 × Genomics {#jcmm14891-sec-0009}
---------------------------------------------------------------------

For our scRNA analysis, we obtained 1597 cells and 1259 cells from hUC‐MSCs and hSF‐MSCs samples, respectively (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). The sequencing saturation for hUC‐MSCs and hSF‐MSCs samples was 43.4% and 18.1%, respectively (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). In hUC‐MSCs, 17 317 genes were detected, with a median of 18 304 UMI Counts per cell, and an average of 65 598 reads per cell (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). There were 104 761 163 reads from hUC‐MSCs, of which, 86.2% had valid barcodes (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). After mapping to the human genome, 78.2% of the reads mapped confidently to the transcriptome, with 81.8% of those reads mapping to exonic regions, 5.9% to intronic regions and 2.1% to intergenic regions (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). In hSF‐MSCs, 16 996 genes were detected, with a median of 12 609 UMI Counts per cell, and an average of 52 245 reads per cell (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). There were 6 577 715 reads from hSF‐MSCs, with 70.4% of those reads containing valid barcodes (Table [1](#jcmm14891-tbl-0001){ref-type="table"}). After mapping to the human genome, 60.4% of those reads mapped confidently to transcriptome, with 63.1% of those reads mapping to exonic regions, 8.1% to intronic regions and 2.6% to intergenic regions (Table [1](#jcmm14891-tbl-0001){ref-type="table"}).

###### 

Summary of single cells sequencing by 10 × Genomics

                                                   hUC‐MSCs      hSF‐MSCs
  ------------------------------------------------ ------------- --------------------
  Cells                                                          
  Estimated number of cells                        1597          1259
  Fraction reads in cells                          81.2%         77.8%
  Mean reads per cell                              65 598        52 245
  Median genes per cell                            3333          2954
  Total genes detected                             17 317        16 996
  Median UMI counts per cell                       18 304        12 609
  Sequencing                                                     
  Number of reads                                  104 761 163   65 777 15
  Valid barcodes                                   86.2%         70.4%
  Reads mapped confidently to transcriptome        78.2%         60.4%
  Reads mapped confidently to exonic regions       81.8%         63.1%
  Reads mapped confidently to intronic regions     5.9%          8.1%
  Reads mapped confidently to intergenic regions   2.1%          2.6%
  Sequencing saturation                            43.4%         18.1%
  Q30 bases in barcode                             47.2%         29.6%
  Q30 bases in RNA read                            89.2%         62.2%
  Q30 bases in sample index                        89.0%         70.9%
  Q30 bases in UMI                                 92.6%         67.5%
  Sample                                                         
  Transcriptome                                                  GRCh38
  Chemistry                                                      Single Cell 3\' v1
  Cell ranger version                                            1.2.0

John Wiley & Sons, Ltd

3.2. Subpopulation discovery in hUC‐MSCs and hSF‐MSCs samples {#jcmm14891-sec-0010}
-------------------------------------------------------------

The Chromium™ single‐cell technology can also be used for scRNA‐seq of primary cells. We isolated more than 1000 cells from hUC‐MSCs and hSF‐MSCs. Gene‐cell matrices from hUC‐MSCs and hSF‐MSCs were concatenated, and PCA was performed to reduce dimensionality before performing clustering and t‐SNE analysis. Based on our PCA and t‐SNE results, there were 11 clusters present in hUC‐MSCs and 7 in hSF‐MSCs (Figures [2](#jcmm14891-fig-0002){ref-type="fig"} and [3](#jcmm14891-fig-0003){ref-type="fig"}).

![The principle components analysis (PCA) and t‐Distributed Stochastic Neighbor Embedding (t‐SNE) for hUC‐MSCs and hSF‐MSCs. A, PCA for hUC‐MSCs, B, PCA for hSF‐MSCs, C, t‐SNE for hUC‐MSCs, D, t‐SNE for hSF‐MSCs](JCMM-24-1945-g002){#jcmm14891-fig-0002}

![Subpopulation discovery in hUC‐MSCs (A‐B) and hSF‐MSCs (C‐D) by t‐SNE analysis. Based on our PCA and t‐SNE results, there were 11 clusters present in hUC‐MSCs and 7 in hSF‐MSCs](JCMM-24-1945-g003){#jcmm14891-fig-0003}

3.3. The DEG profile of hUC‐MSCs and hSF‐MSCs samples {#jcmm14891-sec-0011}
-----------------------------------------------------

By comparing gene expression profiles between subpopulations in hUC‐MSCs, we identified 533 DEGs in cluster 1 (76 up‐regulated and 457 down‐regulated), 57 in cluster 2 (12 up‐regulated and 45 down‐regulated), 32 in cluster 3 (28 up‐regulated and four down‐regulated), 44 in cluster 4 (41 up‐regulated and three down‐regulated), 10 in cluster 5 (seven up‐regulated and three down‐regulated), 319 in cluster 6 (286 up‐regulated and 31 down‐regulated), 731 in cluster 7 (53 up‐regulated and 678 down‐regulated), 1037 in cluster 8 (424 up‐regulated and 613 down‐regulated), 90 in cluster 9 (89 up‐regulated and one down‐regulated), 25 in cluster 10 (24 up‐regulated and one down‐regulated) and 230 in cluster 11 (31 up‐regulated and 199 down‐regulated) (Tables [2](#jcmm14891-tbl-0002){ref-type="table"} and [3](#jcmm14891-tbl-0003){ref-type="table"}). In hSF‐MSCs, there were 204 DEGs in cluster 1 (185 up‐regulated and 19 down‐regulated), 577 in cluster 2 (129 up‐regulated and 448 down‐regulated), 30 in cluster 3 (20 up‐regulated and 10 down‐regulated), 577 in cluster 4 (43 up‐regulated and 534 down‐regulated), 16 in cluster 5 (14 up‐regulated and two down‐regulated), 57 in cluster 6 (51 up‐regulated and down down‐regulated) and 35 in cluster 7 (32 up‐regulated and three down‐regulated) (Tables [2](#jcmm14891-tbl-0002){ref-type="table"} and [4](#jcmm14891-tbl-0004){ref-type="table"}).

###### 

Differentially expressed genes in each cluster of hUC‐MSCs and hSF‐MSCs

  hUC‐MSCs     Differentially expressed genes   hSF‐MSCs   Differentially expressed genes                           
  ------------ -------------------------------- ---------- -------------------------------- ----------- ----- ----- -----
  Cluster 1    76                               457        533                              Cluster 1   185   19    204
  Cluster 2    12                               45         57                               Cluster 2   129   448   577
  Cluster 3    28                               4          32                               Cluster 3   20    10    30
  Cluster 4    41                               3          44                               Cluster 4   43    534   577
  Cluster 5    7                                3          10                               Cluster 5   14    2     16
  Cluster 6    286                              31         319                              Cluster 6   51    6     57
  Cluster 7    53                               678        731                              Cluster 7   32    3     35
  Cluster 8    424                              613        1037                                                      
  Cluster 9    89                               1          90                                                        
  Cluster 10   24                               1          25                                                        
  Cluster 11   31                               199        230                                                       

John Wiley & Sons, Ltd

###### 

Differentially expressed genes in each cluster of hUC‐MSCs

  hUC‐MSCs     Up‐regulated                                                                  Down‐regulated
  ------------ ----------------------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Cluster 1    COTL1; PRDX1; CAPN2; ATP5B; VIM; ACTB; ACTG1; VDAC1; PGK1; ANXA1              HERPUD1; CYR61; MALAT1; NEAT1; ATP2B1; H3F3B; THBS1; COL1A2; COL1A1; FN1
  Cluster 2    TUBA1B; CCT8; ATP5A1; LDHB; VIM; TUFM; C4orf3; TAGLN                          FDPS; ATP5B; HSPA5; PDIA3; COL6A1; SAT1; BRI3; CDKN1A; NEAT1; GADD45A; ANKRD1; LINC00152
  Cluster 3    CDKN1A; FHL2; ADM; MALAT1; H3F3B; RPL22L1; TNFRSF12A; TGFBI; NUPR1; MEST      MGLL; PPP1R14B; SNA12; IER3
  Cluster 4    S100A16; POSTN; TGFBI; SAA1; PELO; BDNF; CTGF; ANKRD1; ACAT2; CTHRC1          PPME1; CITED2; PDLIM1
  Cluster 5    DDIT4; INSIG1; HERPUD1; ATP2B1; MALAT1; TGFBI; TAGLN                          PTMA; H3F3B; MGST3
  Cluster 6    H2AFZ; HMGB1; PTTG1; STMN1; KIAA0101; H;IST1H4C; TUBB4B; HMGB2; SMC4; CCNB1   CDKN2A; IFITM3; C4orf3; TAGLN; GLRX; SAT1; S100A13; SELM; FTL; FTH1
  Cluster 7    EEF1A1; COTL1; RPL31; RPL21; VIM; PDIA3; TGFBI; POSTN; TFPI2; CD59            CYR61; MALAT1; NEAT1; NNMT; HERPUD1; TUBA1A; TUBA1B; KRT10; H3F3B
  Cluster 8    PDIA3; MALAT1; NEAT1; FN1; COL1A1; COL3A1; MT‐ATP6; MT‐CO2; MT‐CO3; MT‐CO1    TPT1; RPS20; RPL12; RPL29; RPL37; RPS12; RPS15A; RPS8; RPL32; RPL18A
  Cluster 9    RPL21; HERPUD1; CYR61; UBC; HSPA5; PCOLCE; MSMO1; ACAT2; TUBA1B; TUBA1A       MALAT1
  Cluster 10   S100A16; HMGA1; ANKRD1; COL4A2; COL1A1; NEAT1; MALAT1; NUPR1; DCN; IGFBP7     COL8A1
  Cluster 11   GHITM; ARF4; VDAC1; ANXA1; YWHAQ; HSP90AA1; ITM2B; RTN4; CNN3                 MEG3; MALAT1; NEAT1; COL6A2; COL6A1; MT‐ATP6; MT‐CO3; FLNA; COL1A1; FN1; STRAP

John Wiley & Sons, Ltd

###### 

Differentially expressed genes in each cluster of hSF‐MSCs

  hSF‐MSCs    Up‐regulated                                                                     Down‐regulated
  ----------- -------------------------------------------------------------------------------- -----------------------------------------------------------------------------------
  Cluster 1   HMGB1; STMN1; H2AFZ; KIAA0101; PTTG1; CKS2; HIST1H4C; TYMS; HMGB2; UBE2C         CDKN2A; FTH1; NUPR1; TGFBI; PAPPA; PSAP; NEAT1; FN1; GAS6; POSTN
  Cluster 2   MALAT1; NEAT1; MT‐ND3; MT‐ND2; MT‐ATP6; MT‐CYB; MT‐CO2; MT‐ND4; MT‐CO3; MT‐CO1   TPT1; FTL; FTH1; TMSB4X; RPL29; RPL23A; RPS12; RPL32; RPL12; RPL18A
  Cluster 3   FTH1; MGLL; SRPX; CD59; ANXA2; S100A4; PGLDA2; C12orf75                          CXCL1; SOX4; NEAT1; MALAT1; FN1; COL1A1; DCN; GJA1; PTGDS; SERPINE1; TUBA1B; CAV1
  Cluster 4   FKBP1A; POLR2L; TXN; S100A11; S100A6; YBX1; RPL31; RPLP0; CD59; ACTB             MALAT1; NEAT1; FN1; COL1A1; COL1A2; EMP1; H3F3B; KRT10; CYR61; TUBA1A
  Cluster 5   POSTN; GAS6; NDUFA4L2; SCG5; RPL22L1; CXCL3; CXCL1; CXCL8; INSIG1; H3F3B         LMO4; TUBA1B
  Cluster 6   DCBLD2; FRMD6; HIF1A; NEAT1; TGFBI; GREM1; ADAMTS1; CCDC80; SERPINE1; PLOD2      LGALS3; B2M; PCOLCE; PPIB; TIMP1; CD63
  Cluster 7   NDUFA4L2; TGFBI; PAPPA; S100A4; CAPG; TNFRSF12A; MGLL; LDHA; LGALS3; S100A16     H3F3B; CALM2; TUBA1B

John Wiley & Sons, Ltd

3.4. GO function analysis of hUC‐MSCs and hSF‐MSCs samples {#jcmm14891-sec-0012}
----------------------------------------------------------

The three main categories for GO function analysis are biological process, cellular component and molecular function. As shown in Figure [4](#jcmm14891-fig-0004){ref-type="fig"}, the DEGs found in hUC‐MSCs were significantly enriched in the following biological processes and molecular functions: cholesterol biosynthesis, calcium‐transporting ATPase activity, corticosterone response, cholesterol biosynthesis, collagen trimer, cyclin‐dependent protein kinase, DNA metabolism, double‐stranded RNA binding, glutathione peroxidase activity, growth factor activity, heparin binding, integrin binding, macromolecular complex binding, MHC class I protein binding, negative regulation of cargo loading, PCNA‐p21 complex, platelet‐derived growth factor binding, protein binding, protein folding, peptide biosynthetic process, protein complex binding, protein targeting to ER, post‐transcriptional regulation of gene expression, regulation of apoptotic process, regulation of cell death, regulation of cellular amino acid metabolism, RNA binding, RNA splicing, ribonucleoprotein complex, secondary alcohol biosynthetic process, SREBP‐SCAP‐Insig complex, SRP‐dependent cotranslational protein, translation, structural molecule activity, transcription factor activity, transcription corepressor activity and unfolded protein binding. Additionally, GO term analysis showed that many of the DEGs function in the extracellular exosome, extracellular matrix, extracellular vesicles, membrane‐bounded vesicles, Lewy bodies, myelin sheath and nucleus, and as structural components in the ribosome and cytoskeleton.

![GO function analysis of the DEGs of hUC‐MSCs. GO classification of differentially regulated genes in cluster 1 (A), cluster 2 (B), cluster 3 (C), cluster 4 (D), cluster 5 (E), cluster 6 (F), cluster 7 (G), cluster 8 (H), cluster 9 (I), cluster 10 (J) and cluster 11 (K). The results were separated into three main categories: biological process, cellular component and molecular function](JCMM-24-1945-g004){#jcmm14891-fig-0004}

In hSF‐MSCs, the cluster 1 DEGs were primarily associated with mitotic cell cycle control and processes, protein binding and RNA binding, and were enriched in membrane‐enclosed lumen and organelle lumen (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}A). The DEGs of cluster 2 were primarily related to SRP‐dependent cotranslational protein targeting, protein targeting to ER and structural molecule activity, and a significant amount is found in cytosolic ribosomes and ribosomal structures (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}B). The DEGs of cluster 3 function in wound healing, vasculature development, platelet‐derived growth factor binding, formation of collagen trimers and extracellular matrix structure (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}C). The DEGs of cluster 4 were related to responding to organic substances, anatomical structure morphogenesis and protein binding and RNA binding, and many of them are found in adherens junctions and anchoring junctions (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}D). The DEGs of cluster 5 were associated with the regulation of cell migration, SREBP‐SCAP‐Insig complex, CXCR chemokine receptor binding and chemokine activity, with many of the DEGs localizing to the extracellular space (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}E). The DEGs of cluster 6 were primarily related to extracellular matrix organization, extracellular structure organization, growth factor binding and glycosaminoglycan binding (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}F). The DEGs of cluster 7 were primarily associated with the negative regulation of ryanodine, regulation of cellular amino acid, glutathione disulphide oxidoreductase and peptide disulphide oxidoreductase and a significant number of the DEGs localized to extracellular exosome, extracellular vesicle (Figure [5](#jcmm14891-fig-0005){ref-type="fig"}G).

![GO function analysis of the DEGs of hSF‐MSCs. GO classification of differentially regulated genes in cluster 1 (A), cluster 2 (B), cluster 3 (C), cluster 4 (D), cluster 5 (E), cluster 6 (F) and cluster 7 (G). The results were separated into three main categories: biological process, cellular component and molecular function](JCMM-24-1945-g005){#jcmm14891-fig-0005}

3.5. KEGG analysis of hUC‐MSCs and hSF‐MSCs samples {#jcmm14891-sec-0013}
---------------------------------------------------

According to KEGG analysis, the DEGs in hUC‐MSC were mainly enriched in Alzheimer\'s disease, amoebiasis, antigen process and presentation, bladder cancer, cell cycle, chemical carcinogenesis, DNA replication, ECM‐receptor interactions, factor‐regulated calcium absorption, focal adhesions, gap junctions, glioma, glutathione metabolism, Hippo signalling pathway, Hunting\'s disease, Huntington\'s disease, xenobiotics metabolism, mineral absorption, nicotinate metabolism, oocyte meiosis, oxidative phosphorylation, p53 signalling pathway, Parkinson\'s disease, pathogenic Escherichia infection, PI3K‐Akt signalling pathway, progesterone oocyte maturation, protein digestion and absorption, protein processing, pyruvate metabolism, and terpenoid backbone biosynthesis, and function in the phagosome, proteasome, ribosome and spliceosome (Figure [6](#jcmm14891-fig-0006){ref-type="fig"}).

![KEGG analysis of the DEGs of hUC‐MSCs. KEGG classification of differentially regulated genes in cluster 1 (A), cluster 2 (B), cluster 3 (C), cluster 4 (D), cluster 5 (E), cluster 6 (F), cluster 7 (G), cluster 8 (H), cluster 9 (I), cluster 10 (J) and cluster 11 (K)](JCMM-24-1945-g006){#jcmm14891-fig-0006}

In hSF‐MSCs, the DEGs in cluster 1 were primarily involved in the spliceosome, cell cycle, p53 signalling pathway, RNA degradation and pathogenic *Escherichia* infection (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}A). The DEGs of cluster 2 were associated with the ribosome, Parkinson\'s disease, oxidative phosphorylation, Huntington\'s disease and Alzheimer\'s disease (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}B). The cluster 3 DEGs were primarily related to amoebiasis, ECM‐receptor interactions, focal adhesions, bacterial invasion of epithelial cells and protein digestion and absorption (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}C). Differentially expressed genes from cluster 4 were primarily associated with the spliceosome, ribosome and focal adhesions, as well as regulation of actin cytoskeleton, and PI3K‐Akt signalling (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}D). In cluster 5, the DEGs were primarily connected to chemokine signalling, Legionellosis, *Salmonella* infection, TNF signalling and cytokine‐cytokine receptor interactions (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}E). The DEGs of cluster 6 were primarily associated with Hippo signalling, proteoglycans expressed in cancer cells, focal adhesions, ECM‐receptor interactions and p53 signalling (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}F). The DEGs of cluster 7 were primarily related to the proteasome and phagosome, as well as pathogenic *Escherichia* infection, gap junction formation and ubiquinone biosynthesis (Figure [7](#jcmm14891-fig-0007){ref-type="fig"}G).

![KEGG analysis of the DEGs of hSF‐MSCs. KEGG classification of differentially regulated genes in cluster 1 (A), cluster 2 (B), cluster 3 (C), cluster 4 (D), cluster 5 (E), cluster 6 (F) and cluster 7 (G)](JCMM-24-1945-g007){#jcmm14891-fig-0007}

4. DISCUSSION {#jcmm14891-sec-0014}
=============

In general, MSCs are increasingly being used as a resource for cell‐based therapies in cartilage repair and regenerative medicine.[32](#jcmm14891-bib-0032){ref-type="ref"}, [33](#jcmm14891-bib-0033){ref-type="ref"} The most effective cell dosages for clinical applications are still unclear; however, it is likely that a large number of MSCs would be needed for both cartilage repair and regenerative medicine. Over the last few years, adipose tissue, bone marrow, synovial fluid and umbilical cord blood have become accessible sources of cells for tissue engineering therapies. Adipose tissue contains MSCs at the highest concentration, and umbilical cord blood can be easily expanded to obtain higher numbers of MSCs.[34](#jcmm14891-bib-0034){ref-type="ref"} Many different laboratories have studied the cell morphology, surface markers and differentiation capacity of stem cells from these sources in order to gain a better understanding of the basic biology of various MSCs.[4](#jcmm14891-bib-0004){ref-type="ref"}, [15](#jcmm14891-bib-0015){ref-type="ref"} In this study, we were able to shed some light on the subgroups present in MSCs and the DEGs within those groups using scRNA‐seq.

Since UC‐MSCs are easily accessible and present fewer ethical problems, they are advantageous as potential resource for cell therapies and clinical applications. Tumorigenesis in UC‐MSCs and UC‐MSC‐derived transplant cells is rarely reported,[34](#jcmm14891-bib-0034){ref-type="ref"}, [35](#jcmm14891-bib-0035){ref-type="ref"} and UC‐MSCs have the potential to differentiate into a variety of different cell types.[36](#jcmm14891-bib-0036){ref-type="ref"}, [37](#jcmm14891-bib-0037){ref-type="ref"}, [38](#jcmm14891-bib-0038){ref-type="ref"}, [39](#jcmm14891-bib-0039){ref-type="ref"} SF‐MSCs provide another source for cell‐based therapies,[16](#jcmm14891-bib-0016){ref-type="ref"} although the success rates for SF‐MSCs are varied and the frequency of SF‐MSCs colony development is low.[40](#jcmm14891-bib-0040){ref-type="ref"} In this study, all cells isolated from the umbilical cord and synovial fluid exhibited typical MSC characteristics with a fibroblastoid morphology, a multipotential differentiation capability and a typical set of surface proteins.

With scRNA‐seq, we obtained 1597 cells and 1259 cells from hUC‐MSCs and hSF‐MSCs samples, respectively. The sequencing saturation for hUC‐MSCs and hSF‐MSCs samples was 43.4% and 18.1%, respectively. After mapping to the human genome, a majority of the reads could be confidently mapped to exonic regions (81.8% for hUC‐MSC and 63.1% for hSF‐MSC). As shown in Figures [2](#jcmm14891-fig-0002){ref-type="fig"} and [3](#jcmm14891-fig-0003){ref-type="fig"}, PCA and t‐SNE analysis unveiled 11 clusters in hUC‐MSCs and 7 in hSF‐MSCs. In hUC‐MSC and hSF‐MSC, the total number of genes detected was 17 317 and 16 996, respectively. By comparing gene expression profiles between subpopulations, we identified 533 DEGs in cluster 1 of hUC‐MCSs, 57 in cluster 2, 32 in cluster 3, 44 in cluster 4, 10 in cluster 5, 319 in cluster 6, 731 in cluster 7, 1037 in cluster 8, 90 in cluster 9, 25 in cluster 10 and 230 in cluster 11 (Table [2](#jcmm14891-tbl-0002){ref-type="table"}). In hSF‐MSCs, there were 204 DEGs in cluster 1, 577 in cluster 2, 30 in cluster 3, 577 in cluster 4, 16 in cluster 5, 57 in cluster 6 and 35 in cluster 7 (Table [2](#jcmm14891-tbl-0002){ref-type="table"}).

The DEGs of hUC‐MSCs and hSF‐MSCs were mainly enriched in several biological processes and molecular functions, including cellular response to corticosterone, cholesterol biosynthetic process, cyclin‐dependent protein kinase, DNA metabolic process, extracellular matrix organization, growth factor activity, macromolecular complex binding, negative regulation of cargo loading, protein binding, protein folding, protein complex binding, protein targeting to ER, post‐transcriptional regulation of gene expression, regulation of apoptotic process, regulation of cell death, regulation of amino acid metabolism, RNA binding, RNA splicing, secondary alcohol biosynthetic process, translation, structural molecule activity, transcription factor activity, transcription corepressor activity and unfolded protein binding. The DEGs were localized to particular cellular components including the extracellular exosome, extracellular matrix, extracellular region, extracellular vesicle, membrane‐bounded vesicle, nucleus, nuclear lumen, ribosome and cytoskeleton.

The DEGs of hUC‐MSCs and hSF‐MSCs were mainly enriched in several signalling pathways, including Alzheimer\'s disease, amoebiasis, antigen processing and presentation, cell cycle, chemical carcinogenesis, DNA replication, ECM‐receptor interactions, factor‐regulated calcium absorption, focal adhesion signalling, gap junction signalling, glioma, glutathione metabolism, Hippo signalling pathway, Huntington\'s disease, mineral absorption, nicotinate metabolism, oocyte meiosis, oxidative phosphorylation, p53 signalling pathway, Parkinson\'s disease, pathogenic Escherichia infection, PI3K‐Akt signalling pathway, progesterone oocyte maturation, protein digestion and absorption, protein processing, proteasome signalling, pyruvate metabolism, ribosome, phagosome, spliceosome and terpenoid backbone biosynthesis.

In summary, our work provides information about the subpopulations and DEGs in hUC‐MSCs and hSF‐MSCs, as identified via scRNA‐seq. In addition, our results show that these DEGs are involved in many pathways, such as p53 signalling, gap junction signalling and PI3K‐Akt signalling, that function in regenerating damaged organs and tissues. Though our results are promising and provide important information about MSCs, the characteristics of hUC‐MSCs and hSF‐MSCs, and the functions of the differentially expressed genes in these subpopulations, need to be studied further.
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